(Q35692019)

9 August 2017

1 reference

title

Inflammation and atherosclerosis (English)

1 reference

9 August 2017

1 reference

2

Deepak L Bhatt

1 reference

9 August 2017

Mehdi H Shishehbor

1

1 reference

9 August 2017

publication date

1 March 2004

1 reference

Current Atherosclerosis Reports

9 August 2017

published in

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

131-139

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-004-0102-x

9 August 2017

exact match

0 references

cites work

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Role of oxidative stress in angiotensin-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0102-X

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

12 December 2020

Relation of inflammation and benefit of statins after percutaneous coronary interventions

1 reference

12 December 2020

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

1 reference

12 December 2020

Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome

1 reference

12 December 2020

P-selectin induces the expression of tissue factor on monocytes

1 reference

12 December 2020

Prothrombotic and antithrombotic pathways in acute coronary syndromes

1 reference

12 December 2020

Need to test the arterial inflammation hypothesis

1 reference

12 December 2020

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis

1 reference

12 December 2020

T-cell-mediated lysis of endothelial cells in acute coronary syndromes

1 reference

12 December 2020

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Detection of activated T lymphocytes in the human atherosclerotic plaque

1 reference

12 December 2020

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

1 reference

12 December 2020

Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway

1 reference

12 December 2020

Dynamics of leukocyte-platelet adhesion in whole blood

1 reference

12 December 2020

Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress

1 reference

12 December 2020

Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?

1 reference

12 December 2020

CD40 signaling in vascular cells: a key role in atherosclerosis?

1 reference

12 December 2020

Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study.

1 reference

12 December 2020

Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin

1 reference

12 December 2020

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy

1 reference

12 December 2020

Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study

1 reference

12 December 2020

Chronic infections and coronary heart disease: is there a link?

1 reference

12 December 2020

Scientific and therapeutic advances in antiplatelet therapy

1 reference

12 December 2020

Elevated serum C-reactive protein levels and early arterial changes in healthy children

1 reference

12 December 2020

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

12 December 2020

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

1 reference

12 December 2020

Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system

1 reference

12 December 2020

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

12 December 2020

Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries

1 reference

12 December 2020

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

1 reference

12 December 2020

A macro and micro view of coronary vascular insult in ischemic heart disease.

1 reference

12 December 2020

Atherosclerosis: the new view

1 reference

12 December 2020

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

1 reference

12 December 2020

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy

1 reference

12 December 2020

Platelet-monocyte aggregates: bridging thrombosis and inflammation

1 reference

12 December 2020

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?

1 reference

12 December 2020

Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction

1 reference

12 December 2020

The oxidative modification hypothesis of atherogenesis: an overview

1 reference

12 December 2020

Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase

1 reference

12 December 2020

Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system

1 reference

12 December 2020

Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography

1 reference

12 December 2020

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

1 reference

12 December 2020

Atherosclerosis. the road ahead

1 reference

12 December 2020

The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms

1 reference

12 December 2020

Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator.

1 reference

12 December 2020

Coming of age of C-reactive protein: using inflammation markers in cardiology

1 reference

12 December 2020

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

12 December 2020

Pathology of the unstable plaque

1 reference

12 December 2020

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

12 December 2020

Inflammation and atherosclerosis

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Statins and the acute-phase response

1 reference

12 December 2020

Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study).

1 reference

12 December 2020

Macrophages and atherosclerotic plaque stability.

1 reference

12 December 2020

Understanding atherosclerosis through mouse genetics

1 reference

12 December 2020

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

1 reference

12 December 2020

Renin-angiotensin system and atherothrombotic disease: from genes to treatment

1 reference

12 December 2020

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

12 December 2020

Increased neutrophil-platelet adhesion in patients with unstable angina

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis

1 reference

12 December 2020

Soluble CD40L and cardiovascular risk in women

1 reference

12 December 2020

The role of platelets in decrypting monocyte tissue factor

1 reference

12 December 2020

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

1 reference

12 December 2020

Using C-reactive protein to assess cardiovascular disease risk

1 reference

12 December 2020

Nitric oxide is a physiological substrate for mammalian peroxidases

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis

1 reference

12 December 2020

Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells

1 reference

12 December 2020

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

12 December 2020

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

1 reference

12 December 2020

Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E

1 reference

12 December 2020

Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors

1 reference

12 December 2020

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

1 reference

12 December 2020

Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

1 reference

12 December 2020

Stabilization of atherosclerotic plaques: new mechanisms and clinical targets

1 reference

12 December 2020

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

1 reference

12 December 2020

Paraoxonase and coronary heart disease

1 reference

12 December 2020

Antibiotic therapy after acute myocardial infarction: a prospective randomized study

1 reference

12 December 2020

Isoprenoids as mediators of the biological effects of statins

1 reference

12 December 2020

Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events

1 reference

12 December 2020

Widespread coronary inflammation in unstable angina

1 reference

12 December 2020

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

1 reference

12 December 2020

10.1007/S11883-004-0102-X

Identifiers

DOI

1 reference

9 August 2017

1 reference